Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endocare launches cryoablation system in China:

This article was originally published in Clinica

Executive Summary

Endocare has launched its CRYOcare system for the treatment of metastatic liver cancer in China. The Irvine, California-based company has already set up a training centre and sold systems to select surgical centres. It has also formed a distribution agreement with Charlson International, which is based in Hong Kong. Endocare says the Chinese market is attractive because the incidence of liver cancer is extremely high compared with Western countries because of the proliferation of the hepatitis virus. Around 10% of the more than 100 million chronic carriers of the Hepatitis B virus are expected to develop primary liver cancers, says Endocare.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075647

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel